All Articles

As NEXGEL prepares for a key investor conference, it faces a crucial test: convincing the market its advanced hydrogel tech can overcome recent financial hurdles.

While media giants crumble under VC pressure, a bootstrapped newsletter hits a $101M valuation. Is 1440's quiet, profitable model the answer?

Beyond the $1M prize, the Hult Prize is an engine for durable value, creating a new class of resilient, purpose-driven ventures investors can't ignore.

For over five years, users have crowned Billtrust an AR automation leader. We dig into why this unbroken streak is more than a trophy—it’s a blueprint.

Eli Lilly's partnership with cash-pay platform Sesame is more than a deal; it's a blueprint for a decentralized, direct-to-consumer healthcare market.

Beyond a simple Father's Day gift, the St. Regis and Drake's partnership reveals a savvy strategy for experiential luxury and market expansion. Here's how.

New data showing a 300% spike in demand for Burmese prescription translations is a stark economic signal of a deeper demographic shift challenging U.S. healthcare.

With a dual Globee Award win, Command Alkon's purpose-built software demonstrates its power to digitally unify a fragmented, foundational industry.

As the deadly Bundibugyo Ebola strain spreads with no approved vaccine, a small pharma company is positioning its cancer drug as a potential broad-spectrum shield.

May's headline job growth masks a troubling reality. New data from Revelio Labs reveals a deepening divide between sectors and a drop in new-hire pay.

Shokz moves beyond its athletic niche with the OpenDots 2 and Air. We analyze if this strategic pivot into the crowded lifestyle audio market is a masterstroke or a misstep.

NASA is outsourcing the brain for its next-gen comms network. Aalyria's Spacetime AI will let satellites 'roam' like cell phones, a critical step in a new hybrid space era.

Beyond the launch, Bank of America’s new instant payment system is a strategic move in a high-stakes race to redefine how money moves across borders.

A new study reveals treating advanced gum disease has up to 10x the environmental impact of prevention, reframing sustainability from recycling to daily habits.

A key regulatory win in Japan propels a potential first-ever treatment for Netherton Syndrome, but the real story is the high-wire act of global commercialization.

As the RTO battle rages, a new tool from Hubstaff promises to end the debate with data. But can an algorithm truly measure productivity, or is it a new panopticon?

Miami's new Jupiter Festival lands Tribeca CEO Rebecca Glashow and NBA legend Kenny Smith, signaling a major new player in the converging world of media and tech.

With record device sales providing a solid financial base, RenovoRx nears a critical milestone in its high-stakes Phase III trial for a new pancreatic cancer therapy.

Beyond greenwashing, the animal health giant's latest report reveals a calculated strategy where innovation, philanthropy, and climate action drive market leadership.

Teva's new Eylea biosimilar hits Europe, a key move in its 'Pivot to Growth' strategy that promises to shake up the lucrative ophthalmology market.